Founded with a mission to accelerate structure-based drug discovery, Health Technology Innovations (HTI) specializes in Cryo-Electron Microscopy (Cryo-EM) and machine learning. HTI provides advanced services for determining the 3D structures of biological macromolecules, which are essential for drug discovery and development. Their offerings include Cryo-EM services, drug discovery services, and specialized software like CryoFAST™ and CryoDiscovery™ for automating image processing. HTI focuses on making these technologies fast, affordable, and scalable for the pharmaceutical and biotechnology markets.

Notable figures associated with HTI include experts in Cryo-EM and machine learning who contribute to the company's innovative solutions. The company has secured investments from leading venture capital firms specializing in biotech and health tech. Key achievements include the development of proprietary software that significantly speeds up the Cryo-EM process, making it more accessible to researchers worldwide. HTI's impact is evident in its contribution to faster and more efficient drug discovery, potentially leading to new treatments for various diseases.